Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SNTI - Senti Biosciences Inc.


3.21
-0.130   -4.050%

Share volume: 20,000
Last Updated: 03-13-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$3.34
-0.13
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024
Report Date 05-09-2023 08-11-2023 11-14-2023 03-21-2024 05-09-2024 08-13-2024 11-14-2024
Total revenue 1.286 M 937.000 K 338.000 K 0.000 0.000 0.000 0.000
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 1.286 M 937.000 K 338.000 K 0.000 0.000 0.000 0.000
    -27.14% -63.93% -100.00% nan% nan% nan%  
Operating expenses 21.120 M 20.572 M 18.523 M 9.111 M 16.301 M 13.356 M 14.902 M
Selling general and admin 9.802 M 9.620 M 9.431 M 8.323 M 7.522 M 4.205 M 6.247 M
Research and development 11.318 M 10.952 M 9.092 M 788.000 K 8.779 M 9.151 M 8.655 M
Total expenses 21.120 M 20.572 M 18.523 M 9.111 M 16.301 M 13.356 M 15.215 M
    -2.59% -9.96% -50.81% 78.92% -18.07% 13.92%  
Operating income -19.834 M -19.635 M -18.185 M -9.111 M -16.301 M -13.356 M -15.215 M
Ebit -19.834 M -19.635 M -18.185 M -9.111 M -16.301 M -11.439 M -29.016 M
Pretax income -18.722 M -18.697 M -36.615 M -9.372 M -12.111 M -11.203 M -28.866 M
    -0.13% 95.83% -74.40% 29.23% -7.50% 157.66%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -18.722 M -18.697 M -14.923 M -18.716 M -12.111 M 0.000 0.000
    0.13% 20.19% -25.42% 35.29% 100.00%    
Net income -18.722 M -18.697 M -14.923 M -18.716 M -12.111 M -11.203 M -28.866 M
    0.13% 20.19% -25.42% 35.29% 7.50% -157.66%